|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 650.60 INR | +13.60% |
|
+37.10% | +47.24% |
| 05-22 | Unichem Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 | CI |
| 05-22 | Unichem Laboratories March-quarter consol profit 109.1 million rupees | RE |
| Market Cap | 45.86B 479M 420M 388M 358M 679M 693M 4.66B 1.81B 22.44B 1.8B 1.76B 77.9B | P/E 2025 |
35.6x | P/E 2026 | 8.19x |
|---|---|---|---|---|---|
| Enterprise Value | 47.96B 501M 439M 406M 375M 710M 725M 4.88B 1.89B 23.47B 1.88B 1.84B 81.48B | EV / Sales 2025 |
2.49x | EV / Sales 2026 | 1.03x |
| Free-Float |
28.71% | Yield 2025 * |
-
| Yield 2026 | - |
| 1 day | +13.60% | ||
| 1 week | +37.10% | ||
| Current month | +40.91% | ||
| 1 month | +82.29% | ||
| 3 months | +97.57% | ||
| 6 months | +54.06% | ||
| Current year | +47.24% |
| 1 week | 454.05 |  | 687.2 |
| 1 month | 376.6 | | 687.2 |
| Current year | 278.2 | | 687.2 |
| 1 year | 278.2 | | 687.2 |
| 3 years | 278.2 | | 937.95 |
| 5 years | 198 | | 937.95 |
| 10 years | 80 | | 937.95 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 2023-08-09 | |
Sanjay Jain
DFI | Director of Finance/CFO | - | 2024-08-07 |
Dhananjay Sathe
CMP | Compliance Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 1977-08-21 | |
Pranay Godha
BRD | Director/Board Member | 53 | 2023-08-09 |
| Director/Board Member | 57 | 2023-08-09 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +13.60% | +37.10% | - | - | 420M | |
| -0.44% | +0.19% | +54.56% | +168.39% | 1,084B | |
| -1.29% | -0.88% | +66.83% | +63.45% | 634B | |
| -0.58% | -3.49% | +32.18% | +87.34% | 447B | |
| -0.04% | -1.99% | +28.73% | +26.18% | 330B | |
| -11.40% | -9.24% | +27.33% | +29.61% | 295B | |
| -1.11% | -2.70% | +27.69% | +45.21% | 285B | |
| -0.93% | -3.57% | -27.74% | -39.70% | 218B | |
| -1.37% | -2.73% | +22.73% | +61.94% | 199B | |
| -1.56% | +2.41% | +18.72% | +77.62% | 169B | |
| Average | -0.11% | +2.52% | +27.89% | +57.78% | 406.65B | |
| Weighted average by Cap. | -1.30% | +2.48% | +39.06% | +84.37% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 21.11B 220M 193M 179M 165M 313M 319M 2.15B 834M 10.33B 828M 810M 35.86B | 22.02B 230M 202M 186M 172M 326M 333M 2.24B 870M 10.78B 864M 845M 37.4B |
| Net income | 1.38B 14.36M 12.6M 11.63M 10.75M 20.37M 20.78M 140M 54.32M 673M 53.93M 52.75M 2.34B | 2.53B 26.41M 23.16M 21.38M 19.76M 37.45M 38.2M 257M 99.88M 1.24B 99.16M 96.99M 4.3B |
| Net Debt | 3.7B 38.66M 33.91M 31.31M 28.93M 54.83M 55.93M 376M 146M 1.81B 145M 142M 6.29B | 2.11B 22M 19.3M 17.82M 16.46M 31.21M 31.83M 214M 83.22M 1.03B 82.62M 80.81M 3.58B |
Employees
2,780
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-09 | ₹650.60 | +13.60% | 9,638,575 |
| 26-07-08 | ₹572.70 | +20.00% | 3,535,394 |
| 26-07-07 | ₹477.25 | +3.11% | 357,939 |
| 26-07-06 | ₹462.85 | -2.15% | 46,828 |
| 26-07-03 | ₹473.00 | +1.58% | 102,928 |
- Stock Market
- Stocks
- UNICHEMLAB Stock
- UNICHEMLAB Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
